Notice: Get a jump on 2015 — Pay your 2015 ASA membership dues now!

>

MEETINGS / EVENTS

RSS

January 23 - 25 2015, 12:00 AM - 12:00 AM

ASA PRACTICE MANAGEMENT 2015

February 07 - 08 2015, 12:00 AM - 12:00 AM

ASA Certificate in Business Administration 2015

June 26 - 28 2015, 12:00 AM - 12:00 AM

Annual Perioperative Surgical Home Summit

>

FDA MEDWATCH ALERTS

December 18, 2014

0.9 Percent Sodium Chloride Injection USP in 100 mL MINI-BAG PLUS Container by Baxter: Recall - Particulate Matter

Summary:

FDA MedWatch Recall - Particulate Matter

November 21, 2014

FDA MedWatch - Respironics California, Esprit V1000 and V200 Ventilators: Class I Recall - Power Failure May Occur

Summary:

FDA MedWatch Respironics California Esprit V1000 and V200 Ventilators Class I Recall

November 21, 2014

FDA MedWatch - Highly Concentrated Potassium Chloride Injection, 10 mEq per 100 mL by Baxter: Recall - Mislabeled

Summary:

Highly Concentrated Potassium Chloride Injection 10 mEq per 100 mL by Baxter Recall Mislabeled

>

ASA FEATURED PRODUCT

Add this product to your shopping cart

Self-Education and Evaluation (SEE) Program

SKU: 30701-14CE

... Read more »

Single Copies, Member Price: $360

HHS OIG Releases Advisory Opinion Finding A Company Model Type Arrangement May Violate the Federal Anti-Kickback Statute

Tuesday, November 12, 2013

ASA applauds the U.S. Department of Health and Human Services Office of the Inspector General's (HHS-OIG) release of Advisory Opinion No. 13-15, which addresses a specific company model-like arrangement in a hospital setting involving anesthesia services and a psychiatry group.  The opinion found that the referenced company model-like arrangement, which would allow the referring physician to retain anesthesia revenue, could violate the Federal Anti-Kickback Statute.

Specifically, HHS-OIG found that the proposed arrangement appeared to be designed to permit the referring physician psychiatry group "to do indirectly what it cannot do directly; that is, to receive compensation, in the form of a portion of Requestor's anesthesia services revenues, in return for the Psychiatry Group's referrals of ECT patients to Requestor for anesthesia services."  The opinion concluded that the proposed arrangement "could potentially generate prohibited remuneration under the Anti-Kickback Statute and that the OIG could potentially impose administrative sanctions" with the caution that "any definitive conclusion regarding the existence of an anti-kickback violation requires a determination of the parties' intent, which…is beyond the scope of the advisory opinion process." 

ASA has repeatedly called for investigations into company model arrangements and ASA members participated in a grassroots call to action voicing opposition to the company model.  The ASA Committee on Practice Management (CoPM) is currently conducting a three-month pilot to solicit information on company model and similar types of arrangements

Review the Advisory Opinion No. 13-15.
Learn more about CoPM's company model pilot member solicitation.

« Back to Washington Alerts